These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22904637)

  • 1. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution.
    Tuca A; Guell E; Martinez-Losada E; Codorniu N
    Cancer Manag Res; 2012; 4():159-69. PubMed ID: 22904637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brazilian Society of Surgical Oncology guidelines for malignant bowel obstruction management.
    Zanatto RM; Lisboa CN; de Oliveira JC; Dos Reis TCDS; Cabral Ferreira de Oliveira A; Coelho MJP; Vidigal BÁ; Ribeiro HSC; Ribeiro R; Fernandes PHS; Braun AC; Pinheiro RN; Oliveira AF; Laporte GA
    J Surg Oncol; 2022 Jul; 126(1):48-56. PubMed ID: 35689586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Management of Inoperable Malignant Bowel Obstruction.
    Huang X; Xue J; Gao M; Qin Q; Ma T; Li X; Wang H
    Ann Pharmacother; 2021 Sep; 55(9):1134-1145. PubMed ID: 33345552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges.
    Gonzalez-Ochoa E; Alqaisi HA; Bhat G; Jivraj N; Lheureux S
    Int J Womens Health; 2022; 14():1849-1862. PubMed ID: 36597479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts in malignant bowel obstruction management.
    Roeland E; von Gunten CF
    Curr Oncol Rep; 2009 Jul; 11(4):298-303. PubMed ID: 19508835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative Medical Management of Inoperable Malignant Bowel Obstruction With "Triple Therapy": Dexamethasone, Octreotide, and Metoclopramide.
    Wey W; Mian M; Calabrese R; Hansen E; Walter M; Wang C; Miller A; Case AA
    Am J Hosp Palliat Care; 2021 Apr; 38(4):340-345. PubMed ID: 33084354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Transesophageal Gastrostomy (PTEG): A Safe and Well-Tolerated Procedure for Palliation of End-Stage Malignant Bowel Obstruction.
    Selby D; Nolen A; Sittambalam C; Johansen K; Pugash R
    J Pain Symptom Manage; 2019 Aug; 58(2):306-310. PubMed ID: 31071424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drainage Percutaneous Endoscopic Gastrostomy for Malignant Bowel Obstruction in Gastrointestinal Cancers: Prognosis and Implications for Timing of Palliative Intervention.
    Pinard KA; Goring TN; Egan BC; Koo DJ
    J Palliat Med; 2017 Jul; 20(7):774-778. PubMed ID: 28437204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.
    Lee YC; Jivraj N; O'Brien C; Chawla T; Shlomovitz E; Buchanan S; Lau J; Croke J; Allard JP; Dhar P; Laframboise S; Ferguson SE; Dhani N; Butler M; Ng P; Stuart-McEwan T; Savage P; Tinker L; Oza AM; Lheureux S
    Obstet Gynecol Int; 2018; 2018():1867238. PubMed ID: 29887891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.
    Madariaga A; Lau J; Ghoshal A; Dzierżanowski T; Larkin P; Sobocki J; Dickman A; Furness K; Fazelzad R; Crawford GB; Lheureux S
    Support Care Cancer; 2022 Jun; 30(6):4711-4728. PubMed ID: 35274188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant bowel obstruction: A retrospective clinical analysis.
    Chen JH; Huang TC; Chang PY; Dai MS; Ho CL; Chen YC; Chao TY; Kao WY
    Mol Clin Oncol; 2014 Jan; 2(1):13-18. PubMed ID: 24649301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral water-soluble contrast for malignant bowel obstruction: open label pilot study.
    Wan Bahrum WFIB; Hardy J; Foster K; Good P
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e794-e797. PubMed ID: 35045980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide for malignant bowel obstruction: twenty years after.
    Mercadante S; Porzio G
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.
    Lee YC; Jivraj N; Wang L; Chawla T; Lau J; Croke J; Allard JP; Stuart-McEwan T; Nathwani K; Bowering V; Karakasis K; O'Brien C; Shlomovitz E; Ferguson SE; Buchanan S; Ng P; Cyriac S; Tinker L; Dhani N; Oza AM; Lheureux S
    J Oncol Pract; 2019 Dec; 15(12):e1066-e1075. PubMed ID: 31550202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
    Hoppenot C; Peters P; Cowan M; Moore ED; Hurteau J; Lee NK; Yamada SD
    Gynecol Oncol; 2019 Jul; 154(1):177-182. PubMed ID: 31056111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonopioid pharmacological management of malignant bowel obstruction: a New Zealand-wide survey.
    Mittal DL; Mittal A; Brosnan EA; Landman WJ
    J Palliat Med; 2014 Nov; 17(11):1249-55. PubMed ID: 25162612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.
    Blair SL; Chu DZ; Schwarz RE
    Ann Surg Oncol; 2001 Sep; 8(8):632-7. PubMed ID: 11569777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
    Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical impact of palliative treatment using octreotide for inoperable malignant bowel obstruction caused by advanced urological cancer.
    Kubota H; Taguchi K; Kobayashi D; Naruyama H; Hirose M; Fukuta K; Kubota Y; Yasui T; Yamada Y; Kohri K
    Asian Pac J Cancer Prev; 2013; 14(12):7107-10. PubMed ID: 24460259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic chemotherapy with 5-fluorouracil and cisplatin for inoperable malignant bowel obstruction because of peritoneal dissemination from gastric cancer.
    Yang S; Li S; Yu H; Li S; Liu W; Liu X; Ma H
    Curr Oncol; 2016 Jun; 23(3):e248-52. PubMed ID: 27330361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.